Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic AD-MSCs in CTD-ILD
NCT06574581Phase 2Recruiting
- Sponsor
- China Medical University Hospital
- Start
- Aug 2024
- Primary completion
- Apr 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of ADSC01 in connective tissue disease-associated interstitial lung disease (CTD-ILD), sponsored by China Medical University Hospital. Started Aug 2024; status: recruiting.
02
Drugs
ADSC01
03
Conditions
connective tissue disease-associated interstitial lung disease (CTD-ILD)
Beyond the preview
Go deeper on NCT06574581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06574581.